Last reviewed · How we verify
placebo (for meperidine)
A placebo produces no pharmacological effect and works through psychological expectation and the placebo effect.
A placebo produces no pharmacological effect and works through psychological expectation and the placebo effect. Used for Control arm in clinical trials comparing efficacy of meperidine.
At a glance
| Generic name | placebo (for meperidine) |
|---|---|
| Also known as | normal saline |
| Sponsor | Konkuk University Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance administered in clinical trials or research settings as a control comparator. It has no active pharmaceutical ingredient and produces therapeutic effects solely through patient expectation, conditioning, and psychological mechanisms. Placebos are used to establish the true efficacy of active drugs by comparison.
Approved indications
- Control arm in clinical trials comparing efficacy of meperidine
Common side effects
Key clinical trials
- Adjunct Sedatives in Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures (PHASE4)
- Efficacy of Pethidine, Ketorolac And Xylocaine Gel As Analgesics For Pain Control In Shockwave Lithotripsy (PHASE4)
- Meperidine for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy. (NA)
- Analgesia During Pediatric Digestive Endoscopy: a Comparison of Two Protocols for Procedural Sedation (PHASE4)
- Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy (PHASE4)
- Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients (EARLY_PHASE1)
- Study to Determine if the Midazolam-Meperidine-Dexmedetomidine is Superior to the Midazolam-Meperidine for Sedation During ERCP (PHASE4)
- Intrathecal Levobupivacaine With Opioids for Caesarean Section (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo (for meperidine) CI brief — competitive landscape report
- placebo (for meperidine) updates RSS · CI watch RSS
- Konkuk University Medical Center portfolio CI